| Income Statement |
| Operating Expenses | 32.47M |
|
| Research and Development Expense | 882.00K |
| Selling, General and Administrative Expense | 8.29M |
| Operating Income | -32.47M |
| Interest Expense | 5.75M |
| Net Income | -104.46M |
| Net Income Common Stock | -104.46M |
| Net Income Common Stock (USD) | -75.69M |
| Consolidated Income | -104.46M |
| Earnings per Basic Share | -0.86 |
| Earnings per Basic Share (USD) | -0.62 |
| Earnings per Diluted Share | -0.86 |
| Earning Before Interest & Taxes (EBIT) | -98.71M |
| Earning Before Interest & Taxes (USD) | -71.53M |
| Weighted Average Shares | 121.59M |
| Weighted Average Shares Diluted | 121.59M |
| Balance Sheet |
| Cash and Equivalents | 25.55M |
| Cash and Equivalents (USD) | 18.52M |
| Investments | 17.80M |
| Investments Current | 17.80M |
| Trade and Non-Trade Receivables | 6.64M |
| Current Assets | 54.32M |
| Property, Plant & Equipment Net | 1.05B |
| Total Assets | 1.13B |
| Debt Current | 16.46M |
| Total Debt | 64.95M |
| Current Liabilities | 110.92M |
| Debt Non-Current | 48.49M |
| Total Liabilities | 951.63M |
| Accumulated Retained Earnings (Deficit) | -914.41M |
| Shareholders Equity | 180.32M |
| Shareholders Equity (USD) | 130.67M |
| Assets Non-Current | 1.08B |
| Total Debt (USD) | 47.07M |
| Liabilities Non-Current | 840.71M |
| Trade and Non-Trade Payables | 92.04M |
| Tax Liabilities | 3.46M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 253.00K |
| Net Cash Flow from Financing | -4.18M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -96.34M |
| Capital Expenditure | -77.07M |
| Issuance (Purchase) of Equity Shares | 3.12M |
| Issuance (Repayment) of Debt Securities | -5.45M |
| Net Cash Flow from Investing | -77.05M |
| Net Cash Flow from Operations | -15.18M |
| Effect of Exchange Rate Changes on Cash | 69.00K |
| Share Based Compensation | 12.11M |